Nkarta, Inc. will host a webcast on November 9, 2026, to present initial clinical data for its NKX019 therapy targeting autoimmune diseases like myositis and systemic sclerosis. The data comes from the Ntrust clinical trials, which test the safety and effectiveness of NKX019, an engineered natural killer cell therapy designed to reset the immune system by eliminating pathogenic B cells. This off-the-shelf therapy aims to offer durable remission for multiple autoimmune conditions. Investors and interested parties can access the webcast live or via replay on Nkarta's website.
Nkarta's upcoming webcast on NKX019 clinical data offers context for readers tracking health sector stocks. As of Nov 07, 2026 03:21 WIB, 83 of 150 health-sector US stocks on Pluang rose while 67 fell. Summit Therapeutics Inc (SMMT) led with a 12.37% gain, trading at USD 15.95, and typical hold time on Pluang was 19 days.
Arcutis Biotherapeutics awarded 58,500 restricted stock units and options for 17,000 shares to six new employees as an inducement to join the company. The grants, approved under Nasdaq Listing Rule 5635(c)(4), vest over four years with specific sched...
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
